Security Snapshot

LEMAITRE VASCULAR INC - Common (LMAT) Institutional Ownership

CUSIP: 525558201

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

172

Shares (Excl. Options)

12.02MFull value: 12,018,919 · shares · 30 Sep 2026

Price

$82.59

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common
Symbol
LMAT on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
12,018,919
Latest holder snapshot 5 signals
Total 13F value
$992,668,280
Portfolio coverage rank
0%
Share change
-735,381
Value change
-$65,765,286
Number of holders
172
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
22,833,049
SEC-reported price per share
$82.59
Insider filing price
$82.59
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • LMAT - LEMAITRE VASCULAR INC - Common is tracked under CUSIP 525558201.
  • 172 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 328 to 172 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.2BFull value: $2,201,244,711 · USD · 30 Jun 2026
    to
    $992.67MFull value: $992,668,280 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 172 institutions filings for Q3 2026.

Open SEC evidence

Security key

525558201

13F reference period

Q3 2026

13F holders

172

13D/G owners

5

CIK / CUSIP context first

Open Q3 2026 holders LMAT full holder history LEMAITRE VASCULAR INC SEC filings LEMAITRE VASCULAR INC company facts LEMAITRE VASCULAR INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
LMAT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% -21% $287,330,114 -$75,053,782 3,102,917 -21% BlackRock, Inc. 31 Mar 2025
Conestoga Capital Advisors, LLC 8.1% 0% $123,875,714 -$24,191,963 1,527,429 -16% Conestoga Capital Advisors 31 Dec 2025
LeMaitre George W 6.4% -15% $159,945,053 -$23,946,211 1,465,235 -13% George W. LeMaitre 31 Mar 2026
FIRST TRUST PORTFOLIOS LP 5.2% $112,839,556 1,175,902 First Trust Portfolios L.P. 30 Jun 2026
Copeland Capital Management, LLC 5.2% $91,579,548 988,980 Copeland Capital Management 31 Dec 2024
As of 30 Sep 2026, 172 institutional investors reported holding
12.02MFull value: 12,018,919 · shares · 30 Sep 2026
shares of LEMAITRE VASCULAR INC - Common (LMAT). This represents 53% of the company’s total
22.83MFull value: 22,833,049 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
46%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIRST TRUST ADVISORS LP 5% 1,135,637 +3.9% 0.06% $93,792,234
CONGRESS ASSET MANAGEMENT CO 4.2% 961,514 -0.23% 0.51% $79,411,454
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 959,529 +0.64% 0% $79,247,500
Copeland Capital Management, LLC 4% 924,081 +10% 1.8% $76,319,922
STATE STREET CORP 4% 908,356 +0.77% 0% $75,021,122
Conestoga Capital Advisors, LLC 3.8% 878,581 -36% 2.2% $72,562,015
GEODE CAPITAL MANAGEMENT, LLC 3.2% 736,781 -6.6% 0% $60,857,863
VANGUARD PORTFOLIO MANAGEMENT LLC 2.7% 612,558 +1.3% 0% $50,591,165
GENEVA CAPITAL MANAGEMENT LLC 2.2% 511,223 -13% 1.2% $42,221,933
DIMENSIONAL FUND ADVISORS LP 2.1% 490,549 -0.68% 0.01% $40,514,579
MORGAN STANLEY 1.6% 360,923 +2.8% 0% $29,808,753
Boston Trust Walden Corp 1.5% 345,634 0.23% $28,545,912
KENNEDY CAPITAL MANAGEMENT LLC 1.2% 277,630 +21% 0.43% $22,929,462
Ranger Investment Management, L.P. 0.94% 215,502 -1.7% 1.7% $17,798,310
Wilshire Advisors LLC 0.73% 166,857 0.03% $13,780,720
VANGUARD FIDUCIARY TRUST CO 0.67% 152,899 +0.38% 0% $12,627,928
Bridge City Capital, LLC 0.51% 116,980 +35% 2% $9,661,378
Public Sector Pension Investment Board 0.49% 111,357 +54% 0.02% $9,152,432
Thrivent Financial for Lutherans 0.49% 110,919 +703% 0.02% $9,160,000
ProShare Advisors LLC 0.45% 102,571 +36% 0.01% $8,471,340
RIVERBRIDGE PARTNERS LLC 0.44% 99,596 +13% 0.24% $8,225,616
Vest Financial, LLC 0.37% 85,152 +11% 0.07% $7,032,704
FEDERATED HERMES, INC. 0.35% 80,179 -2.8% 0.01% $6,621,983
STIFEL FINANCIAL CORP 0.3% 69,095 +5.6% 0% $5,709,110
DIVIDEND ASSETS CAPITAL, LLC 0.3% 68,042 +4.3% 1.1% $5,619,556

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 12,018,919 $992,668,280 -$65,765,286 $82.59 172
2026 Q2 22,933,459 $2,201,244,711 +$66,549,994 $95.96 328
2026 Q1 22,135,274 $2,415,065,943 +$105,205,834 $109.17 340
2025 Q4 21,303,414 $1,727,874,826 +$26,162,852 $81.10 297
2025 Q3 20,972,168 $1,835,216,297 -$5,367,594 $87.51 295
2025 Q2 21,166,185 $1,758,234,218 +$2,582,636 $83.05 283
2025 Q1 21,153,493 $1,775,213,757 -$3,873,253 $83.90 286
2024 Q4 21,174,653 $1,951,282,055 +$12,366,502 $92.14 305
2024 Q3 20,982,696 $1,948,703,180 +$24,926,468 $92.89 289
2024 Q2 20,545,327 $1,690,376,215 +$24,763,593 $82.28 261
2024 Q1 20,244,067 $1,343,284,255 +$11,987,251 $66.36 242
2023 Q4 20,084,131 $1,139,986,402 +$34,733,932 $56.76 226
2023 Q3 19,480,544 $1,061,371,614 +$32,738,721 $54.48 219
2023 Q2 18,811,526 $1,264,888,648 +$4,977,677 $67.28 208
2023 Q1 18,807,566 $968,037,117 -$3,487,147 $51.47 182
2022 Q4 19,244,139 $885,480,684 -$14,154,139 $46.02 181
2022 Q3 19,520,595 $989,204,894 -$6,064,140 $50.68 183
2022 Q2 19,290,567 $878,994,108 +$29,245,065 $45.55 175
2022 Q1 18,775,944 $872,420,057 +$20,477,763 $46.47 175
2021 Q4 18,437,180 $924,595,207 -$12,946,176 $50.23 178
2021 Q3 18,624,446 $989,044,311 +$47,360,392 $53.09 190
2021 Q2 17,706,224 $1,079,385,907 -$8,059,152 $61.02 183
2021 Q1 17,933,078 $875,505,917 +$19,714,714 $48.78 176
2020 Q4 17,703,794 $717,764,963 +$18,469,809 $40.50 168
2020 Q3 17,300,958 $562,850,201 +$13,819,279 $32.53 136
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .